UK markets closed
NIKKEI 225
38,179.46 -49.65 (-0.13%) HANG SENG
19,115.06 +151.38 (+0.80%) CRUDE OIL
79.14 +0.88 (+1.12%) GOLD FUTURES
2,342.50 -32.50 (-1.37%) DOW
39,431.51 -81.33 (-0.21%) Bitcoin GBP
50,244.79 +1,382.34 (+2.83%)
Avenue Therapeutics, Inc. (ATXI)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 2.38M |
| Enterprise value | 599.10k |
| Trailing P/E | N/A |
| Forward P/E | 17.99 |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 1.51 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | N/A |
Trading information
Stock price history
| Beta (5Y monthly) | -0.10 |
| 52-week change 3 | -95.02% |
| S&P500 52-week change 3 | 26.27% |
| 52-week high 3 | 93.7500 |
| 52-week low 3 | 3.8000 |
| 50-day moving average 3 | 9.7799 |
| 200-day moving average 3 | 27.1721 |
Share statistics
| Avg vol (3-month) 3 | 60.65k |
| Avg vol (10-day) 3 | 228.23k |
| Shares outstanding 5 | 595.52k |
| Implied shares outstanding 6 | 619.35k |
| Float 8 | 536.83k |
| % held by insiders 1 | 11.66% |
| % held by institutions 1 | 2.93% |
| Shares short (30 Apr 2024) 4 | 17.13k |
| Short ratio (30 Apr 2024) 4 | 0.34 |
| Short % of float (30 Apr 2024) 4 | 2.88% |
| Short % of shares outstanding (30 Apr 2024) 4 | 2.88% |
| Shares short (prior month 28 Mar 2024) 4 | 3.77k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:75 |
| Last split date 3 | 26 Apr 2024 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -209.03% |
| Return on equity (ttm) | -535.10% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | -10.38M |
| Diluted EPS (ttm) | -73.5000 |
| Quarterly earnings growth (yoy) | 11.30% |
Balance sheet
| Total cash (mrq) | 1.78M |
| Total cash per share (mrq) | 3.02 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 1.55 |
| Book value per share (mrq) | 4.64 |
Cash flow statement
| Operating cash flow (ttm) | -9.45M |
| Levered free cash flow (ttm) | -13.49M |
© 2024 Yahoo. All rights reserved.